Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,963.00
Ask: 1,965.00
Change: -36.00 (-1.81%)
Spread: 2.00 (0.102%)
Open: 2,004.00
High: 2,004.00
Low: 1,958.00
Prev. Close: 1,994.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Markets cautious ahead of US non-farm payrolls

Fri, 02nd Nov 2012 11:30

- All eyes on US jobs data- Outcome could be a major factor in presidential elections- Admiral, Meggitt and RBS disappoint The FTSE 100 was little changed by Friday lunchtime, having trade within a narrow range for most of the morning session, with investors nervous ahead the pivotal employment data due out in the US in the coming hours.Concensus estimates are for a rise of 125,000 in non-farm payrolls in October, higher than the 114,000 gain the month before. Meanwhile, the jobless rate is expected to tick up to 7.9% from 7.8%.Market analyst Craig Erlam from Alpari said: "The US jobs report is always the most anticipated economic data release each month, but this month's carries with it even more importance. While the non-farm payrolls figure is the most important release among traders, as it is seen as a much more reliable indicator of employment, the unemployment figure is what tends to write the headlines."With the presidential elections remaining in a dead heat, the outcome in non-farm payrolls could be a major factor in whether Barack Obama secures another four years as US President, or whether Republican challenger Mitt Romney can secure his place as the premier of the world's largest economy. Election Day is Tuesday.Erlam said that a surprise move in the jobless rate back above 8% would be "devastating" for the Obama campaign: "To have such negative headlines regarding unemployment splashed all over the newspapers days before the people go to the polls is likely to swing the undecided voter in favour of Mitt Romney. And you can guarantee the Romney campaign would capitalise on the rise in unemployment."In other news, the UK economy is not expected to contract this year, but ill-timed fiscal consolidation in Europe and other external risks continue to pose risks, the National Institute of Economic and Social Research (NIESR) said in its latest quarterly forecasts. The British economy is now expected to grow by 0.1% in 2012, which marks a slight upwards revision on its previous forecasts. Next year however the external environment is no longer being forecast to make a contribution to aggregate demand, leading the NIESR to reduce its forecast for gross domestic product (GDP) downwards, to 1.1%, as net trade will not make any positive contribution. FTSE 100: Admiral, Meggit and RBS disappoint with Q3 resultsCar insurance firm Admiral dropped after seeing a 2% decrease in third-quarter turnover. "Little has changed since the half year. The UK car insurance market is cyclical and we are in the softer part of the cycle with premium rates coming down," said Chief Executive Henry Engelhardt. Aerospace, defence and energy components group Meggitt was unwanted after saying that organic revenues were flat year-on-year and revenue growth will be in the mid-single digits in 2013. Banking giant RBS was lower after reporting a statutory loss before tax of £1.26bn for the three months to September 30th after taking a £1.46bn charge in own-credit adjustments and a £400m bill for PPI redress. Investec maintained its 'sell' rating for the stock this morning, saying that it had expected a loss of £1.0bn.Airlines group IAG was among the best performers this morning, up 3% over 168p. Technical analysts at Charles Stanley said: "A close above 168p would suggest that this line is giving way and would amount to a 'trading buy' signal."Oil giant Tullow was a high riser after JPMorgan Cazenove upgraded its stance on the shares to 'overweight'. In contrast, engineering giant Weir was under the weather after Jefferies cut its rating to 'hold' and supermarket group Morrisons fell after Morgan Stanley downgraded the stock to 'underweight'. Shares in luxury brand Burberry were making gains ahead of its first-half results on November 7th. Seymour Pierce has raised its target price and maintained its 'buy' rating this morning, saying that risks to forecasts are now 'on the upside'.FTSE 250: Bumi rises on appointment of Rothschild Group Mining group Bumi advanced after saying it has appointed Rothschild Goup as its financial adviser with immediate effect to evaluate the proposal received from Long Haul Holdings. ??Hotels group Millennium & Copthorne fell despite seeing RevPAR rise 2.6% in the third quarter, with London enjoying an Olympic boost. ??Hikma Pharmaceuticals dropped after saying that it has opted to halt commercial production of generic drugs at Eatontown facility in the US until mid-January while it gets to grips with compliance issues raised by the Food & Drug Administration (FDA). Electrical retailer Dixons continued to make gains on speculation that its main High Street rival Comet could be going into administration.FTSE 100 - RisersInternational Consolidated Airlines Group SA (CDI) (IAG) 168.50p +3.18%Aberdeen Asset Management (ADN) 343.50p +2.54%Tullow Oil (TLW) 1,439.00p +2.27%Intertek Group (ITRK) 2,903.00p +2.25%Whitbread (WTB) 2,442.00p +2.09%GKN (GKN) 216.10p +1.93%Rio Tinto (RIO) 3,222.50p +1.80%Hargreaves Lansdown (HL.) 759.00p +1.67%Capita (CPI) 734.50p +1.66%ITV (ITV) 89.70p +1.59%FTSE 100 - FallersAdmiral Group (ADM) 1,085.00p -4.99%GlaxoSmithKline (GSK) 1,353.50p -2.45%Royal Bank of Scotland Group (RBS) 281.40p -2.02%Morrison (Wm) Supermarkets (MRW) 262.60p -1.83%Petrofac Ltd. (PFC) 1,594.00p -1.79%Pennon Group (PNN) 705.50p -1.67%SSE (SSE) 1,437.00p -1.64%Vodafone Group (VOD) 167.80p -1.29%Smith & Nephew (SN.) 641.00p -1.16%Severn Trent (SVT) 1,578.00p -1.13%FTSE 250 - RisersBumi (BUMI) 277.00p +11.56%Dixons Retail (DXNS) 25.18p +7.70%Chemring Group (CHG) 272.80p +4.68%Homeserve (HSV) 233.30p +4.53%Brown (N.) Group (BWNG) 354.00p +4.21%Jupiter Fund Management (JUP) 279.90p +3.86%Ferrexpo (FXPO) 227.40p +3.46%Spectris (SXS) 1,820.00p +3.41%New World Resources A Shares (NWR) 270.80p +3.40%Perform Group (PER) 407.10p +3.32%FTSE 250 - FallersCentamin (DI) (CEY) 63.50p -5.37%Millennium & Copthorne Hotels (MLC) 495.00p -3.23%Hikma Pharmaceuticals (HIK) 730.00p -3.18%Balfour Beatty (BBY) 313.10p -2.40%Berendsen (BRSN) 577.50p -1.95%COLT Group SA (COLT) 107.00p -1.83%Go-Ahead Group (GOG) 1,304.00p -1.81%Lancashire Holdings (LRE) 859.50p -1.72%Carpetright (CPR) 687.00p -1.65%Synergy Health (SYR) 936.00p -1.63%BC
More News
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.